A review of our peer-reviewed research in the healthcare and mainstream press.
RevenueCycle Intelligence included a June study from The American Journal of Managed Care (AJMC) in its recent story, “Key Ways to Succeed Under MACRA’s Quality Payment Program.” The AJMC study, “Risk Contracting and Operational Capabilities in Large Medical Groups During National Healthcare Reform,” found that only one-third of providers have linked at least 50% of revenue to a risk-based alternate payment model. This slow pace of reform has limited the pace of progress in value-based care, even though CMS has set aggressive goals for Medicare.
A new study in AJMC showing the value of nonclinical benefits for patients with chronic diseases, such as increased productivity and “peace of mind,” received attention this week in news outlets, including Yahoo Finance. Diseases like multiple sclerosis (MS) cause patients fatigue and memory problems, which can limit productivity. Payers that cover newer therapies for MS create value for society, but these benefits often go unrecognized, the study asserted.
Health Equity & Access Weekly Roundup: November 2, 2024
November 2nd 2024This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
HSSP Pharmacists Demonstrate Substantial Cost Avoidance in Specialty Medication Use
October 28th 2024Cost avoidance varied by clinical setting, with the largest savings occurring in hematology clinics ($73,773), followed by rheumatology ($45,330) and pediatric gastrointestinal/irritable bowel syndrome ($16,519).
Read More